Neopharma and GSK partnership produces first line of medicines packaged in UAE
Partners Neopharma & GSK have produced the first batch of medicines at local Secondary Packaging stage
Press Release - 11-Jan-2020
More Related News
-
-
Gsk and Neopharma partnership produces first line of medicines packaged in the UAE as part of vision to become a regional manufacturing hub
Partners GSK and Neopharma have produced the first batch of medicines at local Secondary Packaging stage
Press Release - 08-Jan-2020 -
GSK, Neopharma launch UAE-made medicines
This first batch includes 35,000 packages of medicine
TradeArabia - 08-Jan-2020 -
Neopharma forms JV with Elevar Therapeutics for commercialization of Oncology NCE
Neopharma a global pharmaceutical company will undertake commercializing responsibility through its presence in various countries of MENA & India
Press Release - 31-Oct-2019 -
Neopharma forms JV with Elevar Therapeutics for Commercialization of Oncology NCE
Neopharma a global pharmaceutical company will undertake commercializing responsibility through its presence in various countries of MENA & India.
Press Release - 29-Oct-2019 -
CPhI Middle East & Africa pharma event completes second successful year in the UAE capital
The region's only event dedicated to pharma manufacturing returned to Abu Dhabi, welcoming over 3,100 visitors from 98 countries
Press Release - 16-Oct-2019 -
Sime Darby Oils, Dr. B.R. Shetty's ADVOC announce strategic partnership for MENA region
Via the partnership, SDO and ADVOC will operate in the region as a single sales and marketing team
Press Release - 19-Aug-2019 -
GSK and Neopharma partner to accelerate supply of medicines to patients in the UAE
GSK partners with Neopharma to localize its Secondary Packaging stage - the last phase of the manufacturing process before distribution and sale.
Press Release - 29-Apr-2019 -
Neopharma continues with its Global journey; acquires a manufacturing facility in US from Dr. Reddy's Laboratories
The Bristol site has had a long history first with the British drug maker GlaxoSmithKline (GSK) and then with Dr. Reddy's in manufacturing the brands Augmentin® and Amoxil®.
Press Release - 07-Oct-2018 -
Neopharma acquires a manufacturing facility in US
Neopharma has five globally accredited pharmaceutical manufacturing facilities in three continents
Khaleej Times - 06-Oct-2018 -
Neopharma acquires US antibiotic manufacturing facility
Takeover conducted on Monday for an undisclosed sum
Mubasher - 02-Oct-2018 -
Ministry of Health & Prevention signs agreement with Neopharma Drug Factory to increase emergency medicine inventory
H.E. Dr.
Press Release - 22-Oct-2017 -
UAE based Neopharma invests $240million to manufacture pre-diabetes supplement
The factory in Japan will manufacture supplements for patients in pre-diabetic stage and also Type II diabetic patients.
Press Release - 21-May-2017 -
NeoBiocon Partners with Novartis to offer Vildagliptin for Diabetics in UAE
NeoBiocon, a collaboration between Asia's leading biopharmaceuticals company Biocon Ltd and Dr. B.R. Shetty, Chairman of the UAE-based Neopharma, announced today that it has partnered with Novartis Middle East FZE, to market Jalra (Vildagliptin) and Jalra-M (Vildagliptin + Metformin) in UAE. This partnership will help NeoBiocon expand its product offerings in the
Press Release - 09-Dec-2015